Branded Generics in Emerging Markets Competitor Analysis 2012-2016 and Forecast 2017-2023 : Abbott Laboratories, Apotex, AstraZeneca, CSPC Pharmaceutical Group Limited and Others

Branded Generics in Emerging Countries report gives comprehensive outlook on branded generics across the emerging countries with special emphasis on key regions such as BRICS, ASEAN, and Latin America regions. This report on branded generics in emerging countries gives historical, current, and future market sizes (US$ Mn) of disease indications, route of administration, distribution channels, and geographic regions. This report studies branded generics market dynamics in emerging countries elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market.

Request sample copy at: http://www.reportsweb.com/inquiry&RW00011411921/sample

Key players profiles in the global Branded Generics in Emerging Countries include:
-Abbott Laboratories (U.S.)
-Apotex Inc. (Canada)
-AstraZeneca (U.K)
-CSPC Pharmaceutical Group Limited. (China)
-Dr. Reddy's Laboratories Ltd. (India)
-GlaxoSmithKline plc (U.K)
-Mylan N.V. (U.S.)
-Nichi-Iko Pharmaceutical Co., Ltd ( Japan)
-Novartis AG (Switzerland)
-Pfizer Inc. (U.S)
-Sanofi (France)
-Sun Pharmaceutical Industries Ltd. (India)
-Teva Pharmaceutical Industries Ltd (Israel)
-Valeant Pharmaceuticals International, Inc. (Canada)

In addition, branded generics in emerging countries report includes new product introductions, recent drug patent expiration data, regulatory scenario, collaborations & distribution agreements and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the branded generics market in emerging countries to better equip the clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Disease Opportunities). Key stakeholders of the branded generics in emerging countries report include suppliers, manufacturers, marketers, engaged in manufacturing and supply of pharmaceutical products.

Have any query? Enquire about report at: http://www.reportsweb.com/inquiry&RW00011411921/buying

Rise in out-of-pocket healthcare expenditure and vast market opportunities expected to drive market revenue growth significantly.

The healthcare spending as % of total private healthcare expenditure is high in major countries such as India, China, and Brazil, which is likely to impact market growth positively over the forecast period. For instance in 2014, According to World Bank global health expenditure database, Out-of-pocket health expenditure (% of private expenditure on health) in India and China were 89.2% and 72.3% respectively. Moreover, several countries in emerging markets witnessing growing middleclass and rise in incomes, which is expected to create significant demand for branded generics in the emerging countries. In addition, emerging countries accounts for more than 50% of branded generics sales across the global, this helps the multinational and local pharmaceutical companies to capitalize the ever-growing market opportunities in the region.

Governments pushing for low cost drugs to improve market access
The rising demand for affordable and high quality medicines in emerging countries and local government's initiative improve the healthcare access by means of building healthcare infrastructure and price regulations paving the way for branded generics, which enjoys loyalty from larger stakeholders. Moreover, the mixed demographic profile, rising chronic diseases creating the demand for high quality branded drugs in the emerging countries. However, unique players need to understand the unique challenge of access and affordability in the region to withstand current market competition and to derive the long-term strategy.

Asia-Pacific region leads the market with higher revenue share and growth
Asia-pacific region leads the branded generics market in emerging countries in terms of revenue in 2016 and projected to remain dominant across the forecast period owing to high out-of-pocket healthcare expenditure, rising prevalence of chronic diseases, and growing middle class population. Latin America presented better growth opportunities for the market players.
Competition Assessment

Read complete report at: http://www.reportsweb.com/branded-generics-in-emerging-markets-and-forecast-2017-2023

About ReportsWeb:

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

This release was published on openPR.